Vaxil Bio Ltd (VXL) — Cash Flow-to-Debt Ratio
Vaxil Bio Ltd (VXL) has a Cash Flow-to-Debt Ratio of -3.50x as of September 2025, meaning its operating cash flow of CA$-28.00K could theoretically repay -4% of its total liabilities (CA$8.00K) in one year. Explore Vaxil Bio Ltd (VXL) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vaxil Bio Ltd Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Vaxil Bio Ltd across 16 annual periods. Also explore Vaxil Bio Ltd (VXL) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Vaxil Bio Ltd (2009–2024)
Year-by-year debt coverage analysis for Vaxil Bio Ltd. For market capitalisation and broader financial context, see market cap of Vaxil Bio Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -14.12x | CA$-240.00K | CA$17.00K | ▼ -113.9% |
| 2023 | -6.60x | CA$-561.00K | CA$85.00K | ▼ -264.2% |
| 2022 | -1.81x | CA$-734.00K | CA$405.00K | ▲ +2.2% |
| 2021 | -1.85x | CA$-1.08 Million | CA$585.00K | ▼ -44.0% |
| 2020 | -1.29x | CA$-1.10 Million | CA$857.00K | ▼ -70.2% |
| 2019 | -0.76x | CA$-596.00K | CA$788.00K | ▲ +63.5% |
| 2018 | -2.07x | CA$-943.00K | CA$455.00K | ▼ -65.0% |
| 2017 | -1.26x | CA$-1.00 Million | CA$797.00K | ▲ +53.0% |
| 2016 | -2.67x | CA$-1.50 Million | CA$561.00K | ▼ -117.0% |
| 2015 | -1.23x | CA$-624.00K | CA$507.00K | ▲ +22.3% |
| 2014 | -1.58x | CA$-128.91K | CA$81.35K | ▲ +73.1% |
| 2013 | -5.90x | CA$-383.44K | CA$64.99K | ▼ -614.5% |
| 2012 | -0.83x | CA$-164.34K | CA$199.02K | ▲ +82.1% |
| 2011 | -4.62x | CA$-457.76K | CA$99.17K | ▲ +53.6% |
| 2010 | -9.96x | CA$-380.10K | CA$38.17K | ▼ -99.3% |
| 2009 | -5.00x | CA$-145.03K | CA$29.03K | — |